Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
trans-resveratrol + biotin
- Development stage
- Unknown
- Lead developer
- Saltvae Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Trans-resveratrol + biotin (marketed under the brand name Resbio) is an oral nutraceutical supplement developed by Saltvae Pharmaceuticals. The formulation combines trans-resveratrol, a natural polyphenol with potent antioxidant and anti-inflammatory properties, with biotin (Vitamin B7), a critical B-complex vitamin. Trans-resveratrol is primarily recognized for its ability to activate sirtuins, particularly SIRT1, which is involved in cellular longevity and metabolic regulation. Biotin serves as an essential cofactor for several carboxylase enzymes, playing a vital role in fatty acid synthesis, amino acid metabolism, and gluconeogenesis. The supplement is marketed for general wellness, providing antioxidant protection and supporting the health of hair, skin, and nails through the promotion of keratin production.
- Brand names
- Resbio
- Other names
- Trans Resveratrol Biotin Capsules
02
Targets
ACC (Acetyl-CoA Carboxylase 1)PROC (Protein C)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on trans-resveratrol + biotin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on trans-resveratrol + biotin.